Global “Risk-On” Rally Across Most Sectors Especially Biotechnology The Bi-Partisan Cliff Deal Nobody Likes (Except the Market)

robaxin 750 mg high Investors like the tax deal as it is favorable to investors despite the tax increases.

Stocks are holding their gains after a “mini-fiscal” cliff deal that drove the Dow and S&P up 1.7% and NASDAQ up 2.4%. Life science stocks soared as they usually trade with the NASDAQ and growth stocks.The IBB and XBI are both up more than 2%. Last week we summarized our biopharmaceutical stock picks which were up 35% or more – AMRI,GILD REGN- and these stocks continued to rally today. A good hedge against the sector is shorting Medivation, Inc. (MDVN) which is down 0.9% today in a soaring market. The stock is up 120% over one year, down 10% off October peak and profit taking is expected.

Later today we will summarize our Diagnostics and Tools Focus Stocks and among the winners today are :

Abaxis(ABAX $37.50) up 1.1%,   click Cepheid (CPHD $35.60) up 5%, Quidel (QDEL $19.90) up 6.6%, Sequenom ($4.89) up 3.7% and ThermoFisher (TMO $64.81) up 1.6%. Cepheid is a recent new buy at $32.


No comments yet.

Leave a Reply